RNA interference (RNAi) therapy offers groundbreaking potential to revolutionize disease treatment by targeting gene silencing. Opportunities lie in developing alternative treatments for conditions ...

University of Queensland research has revealed that double-stranded RNA-based biopesticides (dsRNA) sprayed on plant leaves ...

With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology advances.

A CHEMICAL-FREE alternative to surgical mulesing of sheep is closer with University of Queensland development of technology that improves the efficacy of treatments to hinder and kill blowfly ...

- An update on the Interim clinical results for Cohort 2 is planned for mid-2026- ...

According to Precedence Research, the global RNA analysis market size is expected to be worth USD 23.39 billion by 2035, increasing from USD 10.21 billion in 2026, with a strong CAGR of 9.65% from ...

Suzhou Ribo Life Science Co., Ltd. (HKEX: 06938) ("Ribo") and its subsidiary Ribocure Pharmaceuticals AB ("Ribocure") today ...

The company will use the funds to advance its brain shuttle platform that delivers RNAi therapies across the blood-brain ...

Series A financing will be used to advance Aerska's brain shuttle technology to improve the delivery of RNA interference therapeutics for neurological ...

Brings total funds raised to $60 million since launch, months after its seed funding announcement in October 2025Appoints Arno de Wilde, Philip Scheltens and Alex Colville to its Board of Directors ...

Abstract: The selection of communication frequency band and interference suppression technology are the key factors that affect the inspection quality of unmanned aerial vehicle (UAV). The purpose of ...